Collaborative Medicinal Development, LLC

We are building a growing portfolio of disease modifying drugs for the treatment of both cancer and a number of neurodegenerative diseases, broadly defined as hereditary and sporadic conditions that are characterized by progressive nervous system dysfunction.  To accomplish these goals we are pursuing a two-pronged strategy of both in-house invention and third party in-licensing.

About CMD

Find out about our organization, our mission, our methods, and the results to date.

Learn More →

Management Team

Learn more about the team behind CMD and our unique philosophy and methods.

View Bios →

CMD is a portfolio company of Cthulhu Ventures LLC